Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MK0974 (Telcagepant) for acute migraine
NCT00432237Phase 3Completed
- Sponsor
- Merck & Co.
- Start
- Mar 2007
- Primary completion
- Dec 2007
- Modality
- Small Molecules
01
Overview
A Phase 3 trial of telcagepant in migraine, sponsored by Merck & Co.. Started Mar 2007; status: completed.
02
Drugs
telcagepant
03
Conditions
migraine
Beyond the preview
Go deeper on NCT00432237.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00432237.